A placebo-controlled trial of etanercept, a tumor necrosis factor (TNF) inhibitor, in patients with the cancer anorexia/weight loss syndrome. North Central Cancer Treatment Group (NCCTG) trial N00C1
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: CHI Health Immanuel, Mayo Clinic, Illinois CancerCare
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602877395
